Alexandra Balbir-Gurman
Overview
Explore the profile of Alexandra Balbir-Gurman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gyorfi A, Filla T, Polzin A, Tascilar K, Buch M, Trobs M, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e036730.
PMID: 40008525
Background: Systemic sclerosis (SSc) primary heart involvement (SSc-pHI) is one of the leading causes of mortality in SSc. We aimed to evaluate risk factors for SSc-pHI and its progression and...
2.
Yan Q, Bruni C, Garaiman A, Mihai C, Jordan S, Becker M, et al.
Ann Rheum Dis
. 2025 Feb;
PMID: 39894689
Objectives: Tocilizumab (TCZ), rituximab (RTX), mycophenolate mofetil (MMF), and cyclophosphamide (CYC) are the immunosuppressants (IS) most frequently used for systemic sclerosis-associated interstitial lung disease (SSc-ILD). This post hoc study aimed...
3.
Bjorkekjaer H, Bruni C, Broch K, Brunborg C, Carreira P, Airo P, et al.
Rheumatology (Oxford)
. 2025 Jan;
PMID: 39878955
Objectives: The 2022 European Society of Cardiology and European Respiratory Society (ESC/ERS) Guidelines for pulmonary arterial hypertension (PAH) recommend risk stratification to optimize management. However, the performance of generic PAH...
4.
Del Galdo F, Lescoat A, Conaghan P, Bertoldo E, colic J, Santiago T, et al.
Ann Rheum Dis
. 2025 Jan;
84(1):29-40.
PMID: 39874231
Objectives: To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods: An international task force was...
5.
Jeries H, Braun-Moscovici Y, Balbir-Gurman A
Rambam Maimonides Med J
. 2024 Nov;
15(4).
PMID: 39503548
IgG4-related disease (IgG4-RD) is a rare illness with inflammatory and fibrotic changes in affected organs such as pancreas, thyroid, salivary or lacrimal glands, and retroperitoneal space; rarely other organs may...
6.
Markovich Sholomon S, Giryes S, Shataylo V, Braun-Moscovici Y, Balbir-Gurman A
Isr Med Assoc J
. 2024 Oct;
26(9):583-588.
PMID: 39397505
Background: Serum ferritin is a sensitive inflammatory biomarker reflecting cell damage and oxidative stress in inflammatory rheumatic diseases. The use of ferritin for assessment of systemic sclerosis (SSc) activity, severity,...
7.
Elhai M, Sritharan N, Boubaya M, Balbir-Gurman A, Siegert E, Hachulla E, et al.
Lancet Rheumatol
. 2024 Jan;
4(11):e785-e794.
PMID: 38265945
Background: The current subclassification of systemic sclerosis into cutaneous subtypes does not fully capture the heterogeneity of the disease. We aimed to compare the performances of stratification into LeRoy's cutaneous...
8.
Levanon S, Gotloib V, Kraus Y, Novofastovski I, Brikman S, Fawaz A, et al.
Medicine (Baltimore)
. 2023 Dec;
102(50):e36521.
PMID: 38115301
Renal involvement represents the major long-term morbidity associated with IgA vasculitis (IgAV). Our aim was to evaluate clinical characteristics and long-term renal outcomes of IgAV in pediatrics and adults comparing...
9.
Lepri G, Airo P, Distler O, Andreasson K, Braun-Moscovici Y, Hachulla E, et al.
J Scleroderma Relat Disord
. 2023 Sep;
8(3):210-220.
PMID: 37744053
Background: Several studies described the cross-sectional characteristics of systemic sclerosis patients and coexisting primary biliary cholangitis, but longitudinal prognostic data are lacking. Aims: To describe the systemic sclerosis-primary biliary cholangitis...
10.
Campochiaro C, Allanore Y, Braun-Moscovici Y, Matucci-Cerinic M, Balbir-Gurman A
Autoimmun Rev
. 2023 Sep;
23(1):103439.
PMID: 37690478
Cyclophosphamide (CYC) has been a gold standard of treatment for severe progressive Systemic Sclerosis (SSc), especially in patients with concomitant interstitial lung disease (ILD). This approach was based on results...